Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 177

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 177
---
)(42,987)(27,230)Foreign(6,922)779 (1,134)State(9,717)(9,141)(4,743)Total deferred(67,194)(51,349)(33,107)Total provision for income taxes$67,823 $100,914 $130,379 Reconciliations of the statutory U.S. federal income tax rate to effective tax rates are as follows:Fiscal Year202420232022U.S. statutory income tax rate21.0 %21.0 %21.0 %Foreign tax rate differences11.1 1.5 0.4 State income taxes, net of federal tax benefit(1.2)1.7 2.3 Non-deductible compensation5.2 0.8 0.9 Research tax credits and enhanced deductions(29.3)(5.0)(3.8)Stock-based compensation2.6 (0.1)(1.4)Enacted tax rate changes3.0 (0.1)0.4 Tax on unremitted earnings10.7 1.7 1.6 Impact of tax uncertainties0.6 (0.3)(1.3)Impact of acquisitions and restructuring1.3 (4.2)2.0 Net operating loss deferred tax asset recognition, net of valuation allowance (NOL DTA)(0.9)0.2 (0.8)Global intangible low-taxed income6.3 1.5 0.8 Foreign-derived intangible income(7.6)(1.4)(1.4)Goodwill Impairment48.5 — — Foreign Local Tax1.6 0.7 0.6 Other(0.1)(0.6)(0.4)Effective income tax rate72.8 %17.4 %20.9 %

89

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The components of deferred tax assets and liabilities are as follows:December 28, 2024December 30, 2023(in thousands)Deferred tax assets:Compensation$34,932 $30,167 Accruals and reserves17,523 19,121 Net operating loss and credit carryforwards348,228 379